Operating Income Summary of Bausch Health Companies Inc.

Bausch Health Companies Inc.'s latest annual operating income in 2023 was 963 Million USD , down -29.71% from previous year.
Bausch Health Companies Inc.'s latest quarterly operating income in 2024 Q3 was 318 Million USD , down -25.34% from previous quarter.
Bausch Health Companies Inc. reported an annual operating income of 1.37 Billion USD in 2022, up 13.22% from previous year.
Bausch Health Companies Inc. reported an annual operating income of 1.21 Billion USD in 2021, up 78.99% from previous year.
Bausch Health Companies Inc. reported a quarterly operating income of 425.91 Million USD for 2024 Q2, up 45.52% from previous quarter.
Bausch Health Companies Inc. reported a quarterly operating income of 318 Million USD for 2024 Q3, down -25.34% from previous quarter.

Annual Operating Income Chart of Bausch Health Companies Inc. (2023 - 1993)

Historical Annual Operating Income of Bausch Health Companies Inc. (2023 - 1993)

Year	Operating Income	Operating Income Growth
2023	963 Million USD	-29.71%
2022	1.37 Billion USD	13.22%
2021	1.21 Billion USD	78.99%
2020	676 Million USD	1026.03%
2019	-73 Million USD	96.94%
2018	-2.38 Billion USD	-2437.25%
2017	102 Million USD	118.02%
2016	-566 Million USD	-136.41%
2015	1.55 Billion USD	-23.78%
2014	2.03 Billion USD	598.09%
2013	-409.5 Million USD	-613.9%
2012	79.68 Million USD	-73.43%
2011	299.95 Million USD	372.48%
2010	-110.08 Million USD	-160.77%
2009	181.15 Million USD	45.96%
2008	124.1 Million USD	-33.99%
2007	188.01 Million USD	-18.09%
2006	229.53 Million USD	48.79%
2005	154.26 Million USD	45.28%
2004	106.18 Million USD	527.0%
2003	16.93 Million USD	-87.39%
2002	134.28 Million USD	-46.64%
2001	251.63 Million USD	92.99%
2000	130.39 Million USD	72.7%
1999	75.5 Million USD	53.77%
1998	49.1 Million USD	30.93%
1997	37.5 Million USD	59.57%
1996	23.5 Million USD	803.85%
1995	2.6 Million USD	-10.34%
1994	2.9 Million USD	1550.0%
1993	-200 Thousand USD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	292.68 Million USD	-19.15%
2024 Q2	425.91 Million USD	45.52%
2024 Q3	318 Million USD	-25.34%
2023 Q1	175 Million USD	-55.92%
2023 Q2	412 Million USD	135.43%
2023 Q3	14 Million USD	-96.6%
2023 FY	963 Million USD	-29.71%
2023 Q4	362 Million USD	2485.71%
2022 Q2	289 Million USD	1.4%
2022 Q3	244 Million USD	-15.57%
2022 FY	1.37 Billion USD	13.22%
2022 Q4	397 Million USD	62.7%
2022 Q1	285 Million USD	-22.34%
2021 Q4	367 Million USD	-36.06%
2021 FY	1.21 Billion USD	78.99%
2021 Q1	-221 Million USD	-4320.0%
2021 Q3	574 Million USD	312.59%
2021 Q2	-270 Million USD	-22.17%
2020 Q2	-27 Million USD	-110.89%
2020 Q4	-5 Million USD	-101.09%
2020 FY	676 Million USD	1026.03%
2020 Q1	248 Million USD	123.05%
2020 Q3	460 Million USD	1803.7%
2019 Q4	-1.07 Billion USD	-427.05%
2019 Q3	329 Million USD	28.02%
2019 Q2	257 Million USD	-10.45%
2019 Q1	287 Million USD	1048.0%
2019 FY	-73 Million USD	96.94%
2018 FY	-2.38 Billion USD	-2437.25%
2018 Q1	-2.28 Billion USD	-608.39%
2018 Q2	-245 Million USD	89.26%
2018 Q3	117 Million USD	147.76%
2018 Q4	25 Million USD	-78.63%
2017 Q2	175 Million USD	-17.06%
2017 Q3	38 Million USD	-78.29%
2017 Q4	-322 Million USD	-947.37%
2017 FY	102 Million USD	118.02%
2017 Q1	211 Million USD	39.74%
2016 Q2	80.5 Million USD	21.6%
2016 FY	-566 Million USD	-136.41%
2016 Q4	151 Million USD	117.5%
2016 Q3	-863 Million USD	-1172.05%
2016 Q1	66.2 Million USD	-70.17%
2015 FY	1.55 Billion USD	-23.78%
2015 Q4	221.9 Million USD	-50.45%
2015 Q1	543.4 Million USD	-15.63%
2015 Q2	341.5 Million USD	-37.15%
2015 Q3	447.8 Million USD	31.13%
2014 Q4	644.1 Million USD	-5.82%
2014 Q1	356.6 Million USD	59.57%
2014 Q2	355.1 Million USD	-0.42%
2014 FY	2.03 Billion USD	598.09%
2014 Q3	683.9 Million USD	92.59%
2013 Q4	223.47 Million USD	125.07%
2013 FY	-409.5 Million USD	-613.9%
2013 Q3	-891.49 Million USD	-729.98%
2013 Q2	141.51 Million USD	20.95%
2013 Q1	117 Million USD	219.29%
2012 Q2	86.81 Million USD	41.16%
2012 Q4	-98.08 Million USD	-432.9%
2012 Q1	61.49 Million USD	1196.58%
2012 Q3	29.46 Million USD	-66.06%
2012 FY	79.68 Million USD	-73.43%
2011 Q1	75.12 Million USD	253.47%
2011 Q3	112.35 Million USD	-5.16%
2011 Q4	-5.6 Million USD	-104.99%
2011 FY	299.95 Million USD	372.48%
2011 Q2	118.46 Million USD	57.68%
2010 Q3	-126.31 Million USD	-358.77%
2010 Q2	48.81 Million USD	198.23%
2010 Q4	-48.95 Million USD	61.25%
2010 FY	-110.08 Million USD	-160.77%
2010 Q1	16.36 Million USD	-72.09%
2009 Q2	10.54 Million USD	-80.33%
2009 FY	181.15 Million USD	45.96%
2009 Q1	53.61 Million USD	45.38%
2009 Q4	58.64 Million USD	0.52%
2009 Q3	58.34 Million USD	453.18%
2008 FY	124.1 Million USD	-33.99%
2008 Q4	36.87 Million USD	-24.17%
2008 Q3	48.63 Million USD	300.37%
2008 Q2	-24.27 Million USD	-138.44%
2008 Q1	63.14 Million USD	285.2%
2007 Q1	98.64 Million USD	-15.23%
2007 Q2	62.46 Million USD	-36.68%
2007 FY	188.01 Million USD	-18.09%
2007 Q3	61 Million USD	-2.34%
2007 Q4	-34.09 Million USD	-155.89%
2006 FY	229.53 Million USD	48.79%
2006 Q4	116.37 Million USD	328.53%
2006 Q3	-50.92 Million USD	-158.81%
2006 Q2	86.59 Million USD	11.74%
2006 Q1	77.49 Million USD	792.63%
2005 Q3	127.19 Million USD	743.44%
2005 Q4	-11.18 Million USD	-108.8%
2005 FY	154.26 Million USD	45.28%
2005 Q2	15.08 Million USD	-28.34%
2005 Q1	21.04 Million USD	144.53%
2004 Q4	-47.26 Million USD	-175.67%
2004 Q1	31.29 Million USD	133.02%
2004 Q3	62.45 Million USD	4.6%
2004 Q2	59.7 Million USD	90.81%
2004 FY	106.18 Million USD	527.0%
2003 Q3	31.24 Million USD	387.93%
2003 FY	16.93 Million USD	-87.39%
2003 Q1	74.04 Million USD	184.77%
2003 Q4	-94.75 Million USD	-403.3%
2003 Q2	6.4 Million USD	-91.35%
2002 Q3	88.02 Million USD	15.24%
2002 Q1	57.22 Million USD	-31.96%
2002 FY	134.28 Million USD	-46.64%
2002 Q4	-87.35 Million USD	-199.23%
2002 Q2	76.38 Million USD	33.49%
2001 Q2	57.13 Million USD	28.71%
2001 FY	251.63 Million USD	92.99%
2001 Q1	44.38 Million USD	-21.49%
2001 Q4	84.09 Million USD	27.38%
2001 Q3	66.02 Million USD	15.56%
2000 Q4	56.54 Million USD	47.9%
2000 Q3	38.22 Million USD	78.61%
2000 Q1	14.22 Million USD	-47.53%
2000 FY	130.39 Million USD	72.7%
2000 Q2	21.4 Million USD	50.51%
1999 Q2	15.5 Million USD	32.48%
1999 Q1	11.7 Million USD	-29.94%
1999 Q3	21.3 Million USD	37.42%
1999 Q4	27.1 Million USD	27.23%
1999 FY	75.5 Million USD	53.77%
1998 Q2	10.2 Million USD	21.43%
1998 Q4	16.7 Million USD	19.29%
1998 FY	49.1 Million USD	30.93%
1998 Q1	8.4 Million USD	-40.43%
1998 Q3	14 Million USD	37.25%
1997 Q3	10 Million USD	33.33%
1997 FY	37.5 Million USD	59.57%
1997 Q2	7.5 Million USD	27.12%
1997 Q1	5.9 Million USD	-6.35%
1997 Q4	14.1 Million USD	41.0%
1996 Q4	6.3 Million USD	-3.08%
1996 Q1	5 Million USD	156.82%
1996 FY	23.5 Million USD	803.85%
1996 Q2	5.8 Million USD	16.0%
1996 Q3	6.5 Million USD	12.07%
1995 Q2	2.6 Million USD	85.71%
1995 Q1	1.4 Million USD	115.05%
1995 Q3	3 Million USD	15.38%
1995 Q4	-8.8 Million USD	-393.33%
1995 FY	2.6 Million USD	-10.34%
1994 Q4	-9.3 Million USD	-275.47%
1994 Q1	2.5 Million USD	0.0%
1994 Q2	1.3 Million USD	-48.0%
1994 Q3	5.3 Million USD	307.69%
1994 FY	2.9 Million USD	1550.0%
1993 FY	-200 Thousand USD	0.0%

Peer Operating Income Comparison of Bausch Health Companies Inc.

Name	Operating Income	Operating Income Difference
Amneal Pharmaceuticals, Inc.	204.37 Million USD	-371.195%
Catalent, Inc.	-749 Million USD	228.571%
Emergent BioSolutions Inc.	-726.4 Million USD	232.572%
Elanco Animal Health Incorporated	326 Million USD	-195.399%
Perrigo Company plc	151.9 Million USD	-533.97%
Teva Pharmaceutical Industries Limited	433 Million USD	-122.402%
Zoetis Inc.	3.06 Billion USD	68.622%

Global Stocks Search

Bausch Health Companies Inc. (BHC)

Operating Income Summary of Bausch Health Companies Inc.

Annual Operating Income Chart of Bausch Health Companies Inc. (2023 - 1993)

Historical Annual Operating Income of Bausch Health Companies Inc. (2023 - 1993)

Peer Operating Income Comparison of Bausch Health Companies Inc.